Hedley Mary Lynne
- SEC CIK
- 0001340823
No open-market purchases or sales filed in the past year.
Current role at each company
- VEEV Veeva Systems IncDirectoras of Sep 3, 2026
- CNTA Centessa Pharmaceuticals plcDirectoras of Jun 24, 2026
- LLY Eli Lilly & CoDirectoras of Dec 16, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Hedley Mary Lynne as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
VEEV Veeva Systems Inc
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 28, 2023 (view filing) | Dec 27-28 | 1 day | Hedley Mary LynneDirector | SSaleClass A Common Stock | −83 | $191.02 | −$15.9K | −2.0%4.13K after | 2 lots10b5-1 |
| Jul 13, 2023 (view filing) | Jul 12-13 | 1 day | Hedley Mary LynneDirector | SSaleClass A Common Stock | −230 | $207.87 | −$47.8K | −6.0%3.61K after | 2 lots10b5-1 |
| Jul 19, 2021 (view filing) | Jul 15 | 4 days | Hedley Mary LynneDirector | SSaleClass A Common Stock | −94 | $314.81 | −$29.6K | −5.1%1.74K after |